Pls like, _老虎社区_美港股上老虎

Milopowder
2021-12-16

Pls like, thanks

Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln

Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln.Nova

Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":690136459,"tweetId":"690136459","gmtCreate":1639646343670,"gmtModify":1639646343894,"author":{"id":3583235292459629,"idStr":"3583235292459629","authorId":3583235292459629,"authorIdStr":"3583235292459629","name":"Milopowder","avatar":"https://static.tigerbbs.com/af7c551102488406a8f7f878051ada74","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Pls like, thanks</p></body></html>","htmlText":"<html><head></head><body><p>Pls like, thanks</p></body></html>","text":"Pls like, thanks","highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/690136459","repostId":1126164577,"repostType":4,"repost":{"id":"1126164577","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639646138,"share":"https://www.laohu8.com/m/news/1126164577?lang=&edition=full","pubTime":"2021-12-16 17:15","market":"us","language":"en","title":"Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln","url":"https://stock-news.laohu8.com/highlight/detail?id=1126164577","media":"Tiger Newspress","summary":"Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln.Nova","content":"<p>Novartis&nbsp;jumped&nbsp;over&nbsp;3%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;it&nbsp;launched new shares buyback of up to $15 bln.<img src=\"https://static.tigerbbs.com/7efcb788671a6965cf04c7ebd432ebe9\" tg-width=\"766\" tg-height=\"560\" width=\"100%\" height=\"auto\">Novartis AG&nbsp;is launching a new share buyback worth up to $15 billion to be executed by the end of 2023, it said on Thursday, adding it was confident in its top-line growth and deep pipeline.</p>\n<p>The buyback is funded through the $20.7 billion the Swiss drugmaker raised by selling its nearly one-third voting stake in Roche&nbsp;back to its cross-town rival last month, Novartis said, adding its capital allocation strategy aimed to combine investing in core business and returning excess capital to shareholders.</p>\n<p>Novartis said it had the flexibility to return value to shareholders \"without compromising the company's capacity for value-creating bolt-on M&amp;A, whilst providing a strong, growing dividend and reinvesting in the business\".</p>\n<p>The Swiss company confirmed it expected sales to grow by 4% or more through 2026.</p>\n<p>The share buyback, to be executed on a second trading line, is expected to start within days.</p>\n<p>Novartis will ask shareholders to approve an additional 10 billion Swiss franc ($10.81 billion) buyback authority at the annual general meeting on March 4 to cover the amount exceeding the 8.8 billion francs still available under the existing shareholder authority granted in 2021, the company said.</p>\n<p>($1 = 0.9252 Swiss francs)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 17:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novartis&nbsp;jumped&nbsp;over&nbsp;3%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;it&nbsp;launched new shares buyback of up to $15 bln.<img src=\"https://static.tigerbbs.com/7efcb788671a6965cf04c7ebd432ebe9\" tg-width=\"766\" tg-height=\"560\" width=\"100%\" height=\"auto\">Novartis AG&nbsp;is launching a new share buyback worth up to $15 billion to be executed by the end of 2023, it said on Thursday, adding it was confident in its top-line growth and deep pipeline.</p>\n<p>The buyback is funded through the $20.7 billion the Swiss drugmaker raised by selling its nearly one-third voting stake in Roche&nbsp;back to its cross-town rival last month, Novartis said, adding its capital allocation strategy aimed to combine investing in core business and returning excess capital to shareholders.</p>\n<p>Novartis said it had the flexibility to return value to shareholders \"without compromising the company's capacity for value-creating bolt-on M&amp;A, whilst providing a strong, growing dividend and reinvesting in the business\".</p>\n<p>The Swiss company confirmed it expected sales to grow by 4% or more through 2026.</p>\n<p>The share buyback, to be executed on a second trading line, is expected to start within days.</p>\n<p>Novartis will ask shareholders to approve an additional 10 billion Swiss franc ($10.81 billion) buyback authority at the annual general meeting on March 4 to cover the amount exceeding the 8.8 billion francs still available under the existing shareholder authority granted in 2021, the company said.</p>\n<p>($1 = 0.9252 Swiss francs)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVS":"诺华"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126164577","content_text":"Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln.Novartis AG is launching a new share buyback worth up to $15 billion to be executed by the end of 2023, it said on Thursday, adding it was confident in its top-line growth and deep pipeline.\nThe buyback is funded through the $20.7 billion the Swiss drugmaker raised by selling its nearly one-third voting stake in Roche back to its cross-town rival last month, Novartis said, adding its capital allocation strategy aimed to combine investing in core business and returning excess capital to shareholders.\nNovartis said it had the flexibility to return value to shareholders \"without compromising the company's capacity for value-creating bolt-on M&A, whilst providing a strong, growing dividend and reinvesting in the business\".\nThe Swiss company confirmed it expected sales to grow by 4% or more through 2026.\nThe share buyback, to be executed on a second trading line, is expected to start within days.\nNovartis will ask shareholders to approve an additional 10 billion Swiss franc ($10.81 billion) buyback authority at the annual general meeting on March 4 to cover the amount exceeding the 8.8 billion francs still available under the existing shareholder authority granted in 2021, the company said.\n($1 = 0.9252 Swiss francs)","news_type":1},"isVote":1,"tweetType":1,"viewCount":1158,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":14,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln

评论（3）

热议股票